|9/19/2018||Changes in responsibility areas of the Orion Group Executive Management Board|
|7/18/2018||Orion Group Half-Year Financial Report January-June 2018|
|7/18/2018||Orion Corporation's financial reporting and Annual General Meeting in 2019|
|4/24/2018||Orion Group Interim Report January-March 2018|
|10/10/2018||Publishing of Orion Corporation's Interim Report for January-September 2018 on 24 October 2018|
|9/17/2018||Creation of novel medicines and better patient care for the future in an ecosystem|
|9/10/2018||Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation|
|7/6/2018||Orion has started a Phase III trial to develop a drug for ALS - The patient recruitment has begun|
As the cost pressures on pharmaceutical companies increase, Orion needs to constantly improve its efficiency to stay competitive. In 2016, the company began a group-wide Lean program, where the entire staff is involved in a culture of continuous improvement. Orion’s shift toward Lean culture received the Lean Prize 2016 from Lean Association of Finland.
11 January 2017 | On 1st November 2016 the Innovative Medicines Initiative (IMI) together with an association of industrial partners came together to support PHAGO, an innovative research project devoted to the development of immunomodulatory therapies for Alzheimer’s disease (AD).